CN Stock MarketDetailed Quotes
605077 Zhejiang Huakang Pharmaceutical
- 13.60
- -0.35-2.51%
Noon Break Jan 8 11:29 CST
4.16BMarket Cap14.67P/E (TTM)
13.99High13.60Low10.00KlotVolume13.95Open13.95Pre Close13.76MTurnover0.33%Turnover Ratio11.20P/E (Static)305.88MShares19.5852wk High1.41P/B4.07BFloat Cap11.4452wk Low15.35Limit Up299.43MShs Float47.57Historical High12.56Limit Down2.80%Amplitude11.44Historical Low0.54Dividend TTM13.76Avg Price6.77KlotAsk3.96%Div YieldTTM100Lot Size3.12KlotBid
Zhejiang Huakang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.12%2.11B | -0.73%1.36B | -2.39%634.82M | 26.48%2.78B | 28.56%2.04B | 44.09%1.37B | 60.42%650.33M | 38.02%2.2B | 33.71%1.59B | 29.92%949.97M |
| Operating revenue | 3.12%2.11B | -0.73%1.36B | -2.39%634.82M | 26.48%2.78B | 28.56%2.04B | 44.09%1.37B | 60.42%650.33M | 38.02%2.2B | 33.71%1.59B | 29.92%949.97M |
| Other operating revenue | ---- | 350.00%46.05M | ---- | 162.58%51.27M | ---- | 46.31%10.23M | ---- | 201.62%19.52M | ---- | 110.72%6.99M |
| Total operating cost | 10.75%1.93B | 5.75%1.23B | 0.90%561.14M | 27.03%2.39B | 28.02%1.74B | 37.78%1.16B | 48.43%556.15M | 34.61%1.89B | 33.63%1.36B | 36.49%845.33M |
| Operating cost | 7.61%1.67B | 1.86%1.06B | -3.40%482.35M | 24.45%2.11B | 25.63%1.55B | 39.01%1.05B | 52.17%499.34M | 38.18%1.7B | 37.09%1.23B | 37.46%751.89M |
| Operating tax surcharges | 5.64%16.45M | 30.51%11.94M | 109.27%6.23M | 121.12%23.5M | 115.13%15.57M | 97.65%9.15M | 44.27%2.98M | 31.03%10.63M | 16.06%7.24M | 27.33%4.63M |
| Operating expense | 41.20%38.59M | 31.63%24.81M | 36.65%10.58M | 25.41%44.9M | 21.02%27.33M | 32.69%18.84M | 22.56%7.74M | 28.97%35.8M | 0.15%22.58M | 10.54%14.2M |
| Administration expense | 81.38%100.53M | 66.82%62.22M | 33.37%26.14M | 16.88%82.78M | 7.42%55.42M | 18.36%37.3M | 36.20%19.6M | 33.77%70.82M | 42.60%51.59M | 28.01%31.51M |
| Financial expense | 980.13%15.09M | 175.57%3.9M | -37.49%4.66M | 135.41%9.6M | 105.99%1.4M | 52.96%-5.16M | 344.07%7.46M | -4,903.44%-27.11M | -383.13%-23.32M | -390.66%-10.97M |
| -Interest expense (Financial expense) | -6.47%25.33M | 7.41%18M | 47.05%9.85M | 160.94%37.15M | 174.65%27.08M | 222.37%16.76M | 694.75%6.7M | 265.39%14.24M | 261.29%9.86M | 151.61%5.2M |
| -Interest Income (Financial expense) | 32.67%-11.5M | 10.64%-9.05M | 1.03%-4.24M | -36.00%-21.21M | -57.99%-17.08M | -74.12%-10.12M | -459.65%-4.29M | -146.58%-15.59M | -33.34%-10.81M | 3.20%-5.81M |
| Research and development | -1.48%93.93M | 7.98%64.03M | 63.87%31.18M | 24.63%124.28M | 33.89%95.34M | 9.69%59.29M | -13.88%19.03M | 18.38%99.71M | 18.90%71.21M | 61.35%54.06M |
| Credit Impairment Loss | -310.83%-7.56M | -263.47%-7.04M | -265.95%-2.04M | 37.76%-4.68M | 83.16%-1.84M | 68.44%-1.94M | 30.63%-556.55K | -79.35%-7.51M | -101.94%-10.93M | -30.81%-6.14M |
| Asset Impairment Loss | ---- | -170.33%-332.74K | -1.48%-336.36K | -10.91%-1.1M | --723.18K | --473.14K | ---331.46K | 12.45%-990.95K | ---- | ---- |
| Other net revenue | 41.99%21.06M | 730.32%20.41M | 52.50%11.89M | 14.01%39.23M | -69.98%14.83M | -94.40%2.46M | -67.67%7.79M | -45.49%34.41M | 31.04%49.41M | 144.20%43.87M |
| Fair value change income | -277.14%-3.59M | 87.90%-450.53K | -106.64%-151.56K | 201.60%9.8M | 514.67%2.03M | -2,381.95%-3.72M | 51,418.32%2.28M | -19,398.96%-9.65M | -70.45%329.75K | 92.72%-150.05K |
| Invest income | 1,990.72%17.08M | 871.59%16.08M | 138.50%10.02M | -78.57%7.06M | -98.16%816.74K | -95.57%1.66M | -79.91%4.2M | -35.90%32.94M | 49.12%44.47M | 92.80%37.33M |
| -Including: Investment income associates | -31.30%7.01M | 5.35%6.31M | -37.99%3.72M | -69.17%11.18M | -59.16%10.2M | -76.02%5.99M | -52.12%5.99M | 89.83%36.26M | 127.53%24.98M | 275.52%24.98M |
| Asset deal income | -1,354.90%-242.96K | ---- | ---- | -118.27%-6.02K | -75.74%19.36K | ---- | ---- | -37.75%32.93K | 72.50%79.82K | 564.52%85.62K |
| Other revenue | 17.50%15.38M | 102.90%12.16M | 99.70%4.39M | 43.66%28.15M | -15.30%13.09M | -52.98%5.99M | -45.14%2.2M | 15.50%19.59M | 27.39%15.45M | 138.42%12.74M |
| Operating profit | -37.42%196.32M | -28.57%147.56M | -16.10%85.56M | 22.29%427.09M | 13.59%313.72M | 39.10%206.57M | 86.04%101.98M | 36.08%349.23M | 33.64%276.19M | 14.41%148.51M |
| Add:Non operating Income | -31.65%499.88K | -83.75%123.16K | -98.59%6.07K | -4.35%1.25M | -32.77%731.36K | 23.99%757.74K | -16.17%428.82K | 247.25%1.31M | 256.08%1.09M | 268.15%611.14K |
| Less:Non operating expense | -31.40%3.26M | -71.01%1.5M | -96.07%64.41K | -23.47%5.94M | 72.54%4.75M | 118.70%5.17M | 9.21%1.64M | 162.89%7.76M | 45.75%2.75M | 465.02%2.36M |
| Total profit | -37.50%193.56M | -27.69%146.19M | -15.16%85.5M | 23.23%422.4M | 12.82%309.71M | 37.76%202.16M | 87.21%100.77M | 34.92%342.78M | 33.86%274.52M | 13.28%146.75M |
| Less:Income tax cost | -82.12%6.17M | -54.70%7.67M | -48.47%5.56M | 112.81%50.02M | 73.42%34.52M | 251.42%16.93M | 204.95%10.79M | 35.39%23.5M | -6.95%19.9M | -65.19%4.82M |
| Net profit | -31.91%187.39M | -25.22%138.52M | -11.16%79.94M | 16.63%372.38M | 8.08%275.19M | 30.50%185.23M | 78.92%89.98M | 34.88%319.28M | 38.61%254.62M | 22.67%141.94M |
| Net profit from continuing operation | -31.91%187.39M | -25.22%138.52M | -11.16%79.94M | 16.63%372.38M | 8.08%275.19M | 30.50%185.23M | 78.92%89.98M | 34.88%319.28M | 38.61%254.62M | 22.67%141.94M |
| Less:Minority Profit | 9.04%476.3K | 146.67%136.46K | -10.53%-60.36K | --931.99K | --436.83K | --55.32K | ---54.61K | ---- | ---- | ---- |
| Net profit of parent company owners | -31.97%186.91M | -25.27%138.38M | -11.15%80M | 16.34%371.45M | 7.91%274.75M | 30.46%185.18M | 79.03%90.03M | 34.88%319.28M | 38.61%254.62M | 22.67%141.94M |
| Earning per share | ||||||||||
| Basic earning per share | -31.52%0.63 | -25.81%0.46 | -10.26%0.35 | 16.43%1.63 | -17.12%0.92 | 0.00%0.62 | 77.27%0.39 | 30.84%1.4 | 32.14%1.11 | 14.81%0.62 |
| Diluted earning per share | -45.65%0.5 | -37.10%0.39 | -28.21%0.28 | 16.43%1.63 | -17.12%0.92 | 0.00%0.62 | 77.27%0.39 | 30.84%1.4 | 32.14%1.11 | 14.81%0.62 |
| Other composite income | -230.94%-2.64K | -127.81%-1.47K | -575.77%-3.16K | 37.10%6.08K | 195.35%2.02K | 346.67%5.28K | 167.20%664.04 | 239.17%4.44K | -320.21%-2.11K | -5,928.85%-2.14K |
| Other composite income of parent company owners | -230.94%-2.64K | -127.81%-1.47K | -575.77%-3.16K | 37.10%6.08K | 195.35%2.02K | 346.67%5.28K | 167.20%664.04 | 239.17%4.44K | ---2.11K | -5,928.85%-2.14K |
| Total composite income | -31.91%187.39M | -25.22%138.52M | -11.16%79.94M | 16.63%372.39M | 8.08%275.19M | 30.51%185.24M | 78.93%89.98M | 34.89%319.28M | 38.61%254.62M | 22.67%141.93M |
| Total composite income of parent company owners | -31.97%186.91M | -25.27%138.38M | -11.15%80M | 16.34%371.46M | 7.91%274.75M | 30.47%185.18M | 79.04%90.03M | 34.89%319.28M | 38.61%254.62M | 22.67%141.93M |
| Total composite income of minority owners | 9.04%476.3K | 146.67%136.46K | -10.53%-60.36K | --931.99K | --436.83K | --55.32K | ---54.61K | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
